Patents by Inventor Regina Scholz

Regina Scholz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9827312
    Abstract: The present invention relates to compositions containing nanoparticies and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: November 28, 2017
    Assignee: MAGFORCE AG
    Inventors: Andreas Jordan, Norbert Waldoefner, Regina Scholz
  • Patent number: 9345768
    Abstract: The present invention relates to nanoparticles, wherein at least one therapeutically active substance is bound to said nanoparticle and wherein the separation of the at least one therapeutically active substance from the nanoparticle is caused or initiated by an alternating magnetic filed. Furthermore, the present invention relates to pharmaceutical compositions, in particular to injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: May 24, 2016
    Assignee: MAGFORCE AG
    Inventors: Andreas Jordan, Norbert Waldoefner, Klaus Decken, Regina Scholz
  • Publication number: 20160067338
    Abstract: The present invention relates to compositions containing nanoparticies and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 10, 2016
    Inventors: Andreas JORDAN, Norbert WALDOEFNER, Regina SCHOLZ
  • Publication number: 20120225128
    Abstract: The present invention relates to compositions containing nanoparticies and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced.
    Type: Application
    Filed: May 11, 2012
    Publication date: September 6, 2012
    Inventors: Andreas JORDAN, Norbert Waldoefner, Regina Scholz
  • Publication number: 20080268061
    Abstract: The present invention relates to nanoparticles, wherein at least one therapeutically active substance is bound to said nanoparticle and wherein the separation of the at least one therapeutically active substance from the nanoparticle is caused or initiated by an alternating magnetic filed. Furthermore, the present invention relates to pharmaceutical compositions, in particular to injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer.
    Type: Application
    Filed: April 12, 2006
    Publication date: October 30, 2008
    Inventors: Andreas Jordan, Norbert Waldoefner, Klaus Decken, Regina Scholz
  • Publication number: 20080187595
    Abstract: The present invention relates to compositions containing nanoparticles and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced.
    Type: Application
    Filed: August 21, 2006
    Publication date: August 7, 2008
    Inventors: Andreas Jordan, Norbert Waldoefner, Regina Scholz